FDA’s accelerated approval program: is change on the way?


11 October 2021 - The U.S. FDA launched its accelerated approval program in 1992, offering a pathway to bring life saving drugs and biologics to the market faster. 

After nearly 30 years, could substantial reforms be on the way?

Read Regulatory Affairs Professional Society article

Michael Wonder

Posted by:

Michael Wonder